ARK Genomic Revolution ETF vs United Airlines Holdings Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while United Airlines Holdings Inc trades at $123.84 (market cap $40.90B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | UAL | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $136.11 |
52-Week Low | $23.09 | $84.57 |
Market Cap | — | $40.90B |
Enterprise Value | — | $57.70B |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
United Airlines (UAL) trades at $126.00, down 2.36% amid broader market volatility, with technical indicators showing a bullish trend near key support at $125. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.19 versus $1.08 expected, and robust profitability metrics like a 25.73% ROE. Recent news highlights Q2 2026 earnings anticipation on July 15, with analysts expecting $1.89 EPS, while expansion initiatives like new Cartagena routes signal growth momentum.
Outlook remains positive driven by earnings strength and analyst consensus, but risks include fuel cost spikes and legal challenges. The stock offers value with a low P/E of 11.27 and upside to the $160.88 price target, though investors should monitor oil price volatility and competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →